Assessing the impact of laws controlling the online availability of 25I-NBOMe, AH-7921, MDPV and MXE – outcomes of a semi-automated e-shop monitoring

References

• Aldridge, J., & Decary-Hetu, D. (2016). Cryptomarkets and the future of illicit drug markets. In J. Mounteney, A. Bo, & A. Oteo (Eds.), The internet and drug markets. (Vol. European Monitoring Centre for Drugs and Drug Addiction: Insigths, pp. 23–30). Luxembourg: Publications Office of the European Union
   Google Scholar
• Barratt, M.J. (2012). Silk Road: eBay for drugs [letter to the editor]. Addiction, 107, 683. doi:10.1111/j.1360-0443.2011.03709.x
   PubMed Web of Science ®Google Scholar
• Barratt, M.J., & Aldridge, J. (2016). Everything you always wanted to know about drug cryptomarkets* (*but were afraid to ask) [Editorial]. International Journal of Drug Policy, 35, 1–6. doi:10.1016/j.drugpo.2016.07.005
   PubMed Web of Science ®Google Scholar
• Barratt, M.J., Ferris, J.A., & Winstock, A.R. (2014). Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States. Addiction, 109, 774–783. doi:10.1111/add.12470
   PubMed Web of Science ®Google Scholar
• Benson, B.L. (2009). Escalating the war on drugs: Causes and unintended consequences. Stanford Law and Policy Review, 20, 293
   Google Scholar
• Blumstein, A. (1993). Making rationality relevant—The American society of criminology 1992 presidential address. Criminology, 31, 1–16. doi:10.1111/j.1745-9125.1993.tb01119.x
   Web of Science ®Google Scholar
• Brunt, T.M., & Niesink, R.J. (2011). The Drug Information and Monitoring System (DIMS) in the Netherlands: Implementation, results, and international comparison. Drug Testing and Analysis, 9, 621–634. doi:10.1002/dta.323
   Web of Science ®Google Scholar
• Caldicott, D., Bright, S.J., & Barratt, M.J. (2013). NBOMe – a very different kettle of fish.NBOMe-a very different kettle of fish. The Medical Journal of Australia, 199, 322. doi:10.5694/mja13.10926
   PubMed Web of Science ®Google Scholar
• Caulkins, J.P. (2007). Price and purity analysis for illicit drug: Data and conceptual issues. Drug and Alcohol Dependence, 90, S61–S68. doi:http://dx.doi.org/10.1016/j.drugalcdep.2006.08.014
   PubMed Web of Science ®Google Scholar
• Caulkins, J.P., Reuter, P., & Coulson, C. (2011). Basing drug scheduling decisions on scientific ranking of harmfulness: False promise from false premises. Addiction, 106, 1886–1890. doi:10.1111/j.1360-0443.2011.03461.x
   PubMed Web of Science ®Google Scholar
• Corazza, O., Assi, S., Simonato, P., Corkery, J., Bersani, F.S., Demetrovics, Z., … Schifano, F. (2013). Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: The outcomes of the ReDNet project. Human Psychopharmacology, 28, 317–323. doi:10.1002/hup.2299
   PubMed Web of Science ®Google Scholar
• Corazza, O., Schifano, F., Simonato, P., Fergus, S., Assi, S., Stair, J., … Davey, Z. (2012a). Phenomenon of new drugs on the Internet: The case of ketamine derivative methoxetamine. Human Psychopharmacology: Clinical and Experimental, 27, 145–149. doi:10.1002/hup.1242
   PubMed Web of Science ®Google Scholar
• Corazza, O., Schifano, F., Simonato, P., Fergus, S., Assi, S., Stair, J., … Scherbaum, N. (2012b). Phenomenon of new drugs on the Internet: The case of ketamine derivative methoxetamine. Human Psychopharmacology, 27, 145–149. doi:10.1002/hup
   PubMed Web of Science ®Google Scholar
• Drapalova, E., & Belackova, V. (2016). Monitoring of discussion forums on new psychoactive substances in the Czech Republic – content and trends. Adiktologie, 16, 130–142
   Google Scholar
• Drapalova, E., Grund, J.P., & Belackova, V. (2016). Evaluating potential hazards of new trends in psychoactive substance use. A literature review of risk assessment procedures. Adiktologie, 16, 144–154
   Google Scholar
• Dresen, S., Ferreiros, N., Putz, M., Westphal, F., Zimmerman, R., & Auwarter, V. (2010). Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. Journal of Mass Spectometry, 45, 1186–1194. doi:10.1002/jms.1811
   PubMed Web of Science ®Google Scholar
• Council Implementing Decision (EU) 2015/1875 of 8 October 2015 on subjecting 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) to control measures, (2015)
   Google Scholar
• EMCDDA. (2002). Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs. Luxembourg. Retrieved from http://www.emcdda.europa.eu/attachements.cfm/att_33346_EN_Risk4.pdf
   Google Scholar
• EMCDDA. (2004). Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs. Luxembourg. Retrieved from http://www.emcdda.europa.eu/attachements.cfm/att_33354_EN_Risk6.pdf
   Google Scholar
• EMCDDA. (2009). Risk assessment of new psychoactive substances – Operating guidelines. Lisbon. doi:10.2810/2428. Retrieved from http://www.emcdda.europa.eu/attachements.cfm/att_100979_EN_RiskGuidelines2010.pdf
   Google Scholar
• EMCDDA. (2012). Online sales of new psychoactive substances/”legal highs”: Summary of results from the 2011 multilingual snapshots. Briefing paper, 8. Retrieved from http://www.emcdda.europa.eu/attachements.cfm/att_143801_EN_SnapshotSummary.pdf
   Google Scholar
• EMCDDA. (2014a). Report on the risk assessment of 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (3,4-methylenedioxypyrovalerone, MDPV) in the framework of the Council Decision on new psychoactive substances. Luxembourg. doi:10.2810/57789. Retrieved from http://www.emcdda.europa.eu/attachements.cfm/att_228256_EN_TDAK14003ENN.pdf
   Google Scholar
• EMCDDA. (2014b). Report on the risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) in the framework of the Council Decision on new psychoactive substances. Luxembourg. doi:10.2810/57161. Retrieved from http://www.emcdda.europa.eu/attachements.cfm/att_228264_EN_TDAK14004ENN.pdf
   Google Scholar
• EMCDDA. (2014c). Report on the risk assessment of 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe) in the framework of the Council Decision on new psychoactive substances. Luxembourg. doi:10.2810/5725. Retrieved from http://www.emcdda.europa.eu/attachements.cfm/att_228239_EN_TDAK14001ENN.pdf
   Google Scholar
• EMCDDA. (2014d). Report on the risk assessment of 3,4-dichloro-N-([1-(dimethylamino)cyclohexyl]methyl)benzamide (AH-7921) in the framework of the Council Decision on new psychoactive substances. Luxembourg. doi:10.2810/5691. Retrieved from http://www.emcdda.europa.eu/attachements.cfm/att_228248_EN_TDAK14002ENN.pdf
   Google Scholar
• EMCDDA. (2015a). Injection of synthetic cathinones. Lisbon. Retrieved from http://www.drugsandalcohol.ie/21967/1/injection.pdf
   Google Scholar
• EMCDDA. (2015b). Online monitoring of New Psychoactive substances (NPS) in the drug markets
   Google Scholar
• EMCDDA, & Europol. (2007). Early-warning system on new psychoactive substances. Operating guidelines (978-92-9168-281-2). Belgium. Retrieved from http://www.emcdda.europa.eu/attachements.cfm/att_52451_EN_EWSguidelines2.pdf
   Google Scholar
• Fitch, C., Stimson, G.V., Jones, S., Hickman, M., Muscat, I., & Gafoor, M. (2003). Responding to Drug Use in Jersey: Findings and outcomes from a multimethod rapid assessment. Drugs: Education, Prevention, and Policy, 10, 223–234. doi:10.1080/0968763031000072666
   Web of Science ®Google Scholar
• Hillebrand, J., Olszewski, D., & Sedefov, R. (2010). Legal highs on the Internet. Substance Use & Misuse, 45, 330–340. doi:10.3109/10826080903443628
   PubMed Web of Science ®Google Scholar
• Kamerer, D. (2013). Estimating online audiences: Understanding the limitations of competitive intelligence services. First Monday, 18(15). doi:10.5210/fm.v18i5.3986. Retrieved from http://firstmonday.org/ojs/index.php/fm/article/view/3986/3674
   Google Scholar
• Kikura-Hanajiri, R., Uchiyama, N., Kawamura, M., & Goda, Y. (2014). Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan. Drug Testing and Analysis, 6, 832–839. doi:10.1016/j.legalmed.2011.02.003
   PubMed Web of Science ®Google Scholar
• Ledberg, A. (2015). The interest in eight new psychoactive substances before and after scheduling. Drug and Alcohol Dependence, 152, 73–78. doi:10.1016/j.drugalcdep.2015.04.020
   PubMed Web of Science ®Google Scholar
• MacCoun, R., & Reuter, P. (1997). Interpreting Dutch cannabis policy: Reasoning by analogy in the legalization debate. Science, 278, 47–52. doi:10.1126/science.278.5335.47
   PubMed Web of Science ®Google Scholar
• MacCoun, R.J. (1993). Drugs and the law: A psychological analysis of drug prohibition. Psychological Bulletin, 113, 497. doi:10.1037/0033-2909.113.3.497
   PubMed Web of Science ®Google Scholar
• Martinez, M., Kmetonyova, D., & Belackova, V. (2016). A method for exploring the number of online shops selling new psychoactive substances: Initial I-TREND project results. In J. Mounteney, A. Bo, & A. Oteo (Eds.), The internet and drug markets. (Vol. European Monitoring Centre for Drugs and Drug Addiction: Insights, pp. 97–104). Luxembourg: Publications Office of the European Union. doi:10.2810/324608
   Google Scholar
• Meyers, K., Kaynak, Ö., Bresani, E., Curtis, B., McNamara, A., Brownfield, K., & Kirby, K.C. (2015). The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases? International Journal of Drug Policy, 26, 670–674. doi:10.1016/j.drugpo.2015.01.012
   PubMed Web of Science ®Google Scholar
• Mounteney, J. (2009). Methods for providing an earlier warning of emerging drug trends. The University of Bergen, Bergen. Retrieved from http://citeseerx.ist.psu.edu/viewdoc/download? doi=10.1.1.557.5974&rep=rep1&type=pdf
   Google Scholar
• Mounteney, J., & Griffiths, P. (2014). Increasing complexity in European drug use: Highlights from the EMCDDA’s 2014 European drug report. Drugs: Education, Prevention and Policy, 21, 482–483. doi:10.3109/09687637.2014.963516
   Web of Science ®Google Scholar
• Nakamoto, S. (2008). Bitcoin: A peer-to-peer electronic cash system. Retrieved from https://bitcoin.org/bitcoin.pdf
   Google Scholar
• Newcombe, R. (2009). The use of mephedrone (M-cat, Meow) in Middlesbrough. Manchester. Retrieved from http://www.lifeline.org.uk/wp-content/_old-site-docs/M-cat%20report%20small.pdf
   Google Scholar
• Nizar, H., Dargan, P.I., & Wood, D.M. (2015). Using Internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance 4-methylaminorex and 4, 4′-dimethylaminorex. Journal of Medical Toxicology, 11, 80–84. doi:10.1007/s13181-014-0425-0
   PubMedGoogle Scholar
• Rácz, J., Csák, R., Tóth, K.T., Tóth, E., Rozmán, K., & Gyarmathy, V.A. (2015). Veni, vidi, vici: The appearance and dominance of new psychoactive substances among new participants at the largest needle exchange program in Hungary between 2006 and 2014. Drug & Alcohol Dependence, 158, 154–158. doi:10.1016/j.drugalcdep.2015.10.034
   PubMed Web of Science ®Google Scholar
• Reinarman, C., Cohen, P.D.A., & Kaal, H.L. (2004). The limited relevance of drug policy: Cannabis in Amsterdam and in San Francisco. American Journal of Public Health, 94, 836–842
   PubMed Web of Science ®Google Scholar
• Rhodes, T., Stimson, G.V., Fitch, C., Ball, A., & Renton, A. (1999). Rapid assessment, injecting drug use, and public health. Lancet, 354, 65–68. doi:10.1016/S0140-6736(98)07612-0
   PubMed Web of Science ®Google Scholar
• Ritter, A., Livingston, M., Chalmers, J., Berends, L., & Reuter, P. (2016). Comparative policy analysis for alcohol and drugs: Current state of the field. International Journal of Drug Policy, 31, 39–50. doi:10.1016/j.drugpo.2016.02.004
   PubMed Web of Science ®Google Scholar
• Ryall, G., & Butler, S. (2011). The great Irish head shop controversy. Drugs: Education, Prevention and Policy, 18, 303–311. doi:10.3109/09687637.2011.560911
   Web of Science ®Google Scholar
• Schmidt, M.M., Sharma, A., Schifano, F., & Feinmann, C. (2011). “Legal highs” on the net—Evaluation of UK-based Websites, products and product information. Forensic Science International, 206, 92–97. doi:10.1016/j.forsciint.2010.06.030
   PubMed Web of Science ®Google Scholar
• Soska, K., & Christin, N. (2015). Measuring the longitudinal evolution of the online anonymous marketplace ecosystem. Paper presented at the 24th USENIX Security Symposium
   Google Scholar
• Thornton, M. (2007). Prohibition versus legalization: Do economists reach a conclusion on drug policy? The Independent Review, 11, 417–433
   Web of Science ®Google Scholar
• Tonry, M. (1995). Malign neglect-race, crime, and punishment in America. New York: Oxford University Press
   Google Scholar
• Van Buskirk, J., Naicker, S., Roxburgh, A., Bruno, R., & Burns, L. (2016). Who sells what? Country specific differences in substance availability on the Agora cryptomarket. International Journal of Drug Policy, 35, 16–23. doi:10.1016/j.drugpo.2016.07.004
   PubMed Web of Science ®Google Scholar
• Van Hout, M.C., & Bingham, T. (2013). ‘Silk Road’, the virtual drug marketplace: A single case study of user experiences. International Journal of Drug Policy, 24, 385–391. doi:10.1016/j.drugpo.2013.01.005
   PubMed Web of Science ®Google Scholar
• Van Hout, M.C., & Bingham, T. (2014). Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading. International Journal of Drug Policy, 25, 183–189. doi:10.1016/j.drugpo.2013.10.009
   PubMed Web of Science ®Google Scholar
• Vardakou, I., Pistos, C., & Spiliopoulou, C. (2011). Drugs for youth via Internet and the example of mephedrone. Toxicology Letters, 201, 191–195. doi:10.1016/j.toxlet.2010.12.014
   PubMed Web of Science ®Google Scholar
• Vermette-Marcotte, A.E., Dargan, P.I., Archer, J.R.H., Gosselin, S., & Wood, D.M. (2014). An Internet snapshot study to compare the international availability of the novel psychoactive substance methiopropamine. Clinical Toxicology, 52, 678–681. doi:10.3109/15563650.2014.933346
   PubMed Web of Science ®Google Scholar
• WHO. (2010). Guidance on the WHO review of psychoactive substances for international control. France. Retrieved from http://www.who.int/medicines/areas/quality_safety/GLS_WHORev_PsychoactSubst_IntC_2010.pdf
   Google Scholar
• Winstock, A.R., & Ramsey, J.D. (2010). Legal highs and the challenges for policy makers. Addiction, 105, 1685–1687. doi:10.1111/j.1360-0443.2010.03163.x
   PubMed Web of Science ®Google Scholar
• Wood, D.M., & Dargan, P.I. (2014). Using Internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance alpha-methyltryptamine (AMT). Substance Use & Misuse, 49, 7–12. doi:10.3109/10826084.2013.808224
   PubMed Web of Science ®Google Scholar